SRTS Quote, Financials, Valuation and Earnings

InfuSystems Holdings has a net margin of 13.75% compared to Sensus Healthcare's net margin of 5.12%. Sensus Healthcare's return on equity of 18.5% beat InfuSystems Holdings's return on equity of 2.8%.

Sensus Healthcare has a consensus price target of $11.50, signalling upside risk potential of 58.84%. On the other hand InfuSystems Holdings has an analysts' consensus of $14.13 which suggests that it could grow by 69.77%. Given that InfuSystems Holdings has higher upside potential than Sensus Healthcare, analysts believe InfuSystems Holdings is more attractive than Sensus Healthcare.

Sensus Healthcare has a beta of 1.215, which suggesting that the stock is 21.498% more volatile than S&P 500. In comparison InfuSystems Holdings has a beta of 1.531, suggesting its more volatile than the S&P 500 by 53.098%.

Sensus Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystems Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare pays -- of its earnings as a dividend. InfuSystems Holdings pays out -- of its earnings as a dividend.

Sensus Healthcare quarterly revenues are $8.8M, which are smaller than InfuSystems Holdings quarterly revenues of $35.3M. Sensus Healthcare's net income of $1.2M is lower than InfuSystems Holdings's net income of $1.8M. Notably, Sensus Healthcare's price-to-earnings ratio is 12.70x while InfuSystems Holdings's PE ratio is 131.42x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare is 2.86x versus 1.35x for InfuSystems Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Retractable Technologies has a net margin of 13.75% compared to Sensus Healthcare's net margin of -18.58%. Sensus Healthcare's return on equity of 18.5% beat Retractable Technologies's return on equity of -16.83%.

Sensus Healthcare has a consensus price target of $11.50, signalling upside risk potential of 58.84%. On the other hand Retractable Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Sensus Healthcare has higher upside potential than Retractable Technologies, analysts believe Sensus Healthcare is more attractive than Retractable Technologies.

Sensus Healthcare has a beta of 1.215, which suggesting that the stock is 21.498% more volatile than S&P 500. In comparison Retractable Technologies has a beta of 1.939, suggesting its more volatile than the S&P 500 by 93.884%.

Sensus Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare pays -- of its earnings as a dividend. Retractable Technologies pays out -3.32% of its earnings as a dividend.

Sensus Healthcare quarterly revenues are $8.8M, which are smaller than Retractable Technologies quarterly revenues of $10.3M. Sensus Healthcare's net income of $1.2M is higher than Retractable Technologies's net income of -$1.9M. Notably, Sensus Healthcare's price-to-earnings ratio is 12.70x while Retractable Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare is 2.86x versus 0.58x for Retractable Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision has a net margin of 13.75% compared to Sensus Healthcare's net margin of -4291.67%. Sensus Healthcare's return on equity of 18.5% beat Catheter Precision's return on equity of -65.84%.

Sensus Healthcare has a consensus price target of $11.50, signalling upside risk potential of 58.84%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 257.14%. Given that Catheter Precision has higher upside potential than Sensus Healthcare, analysts believe Catheter Precision is more attractive than Sensus Healthcare.

Sensus Healthcare has a beta of 1.215, which suggesting that the stock is 21.498% more volatile than S&P 500. In comparison Catheter Precision has a beta of -0.184, suggesting its less volatile than the S&P 500 by 118.441%.

Sensus Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

Sensus Healthcare quarterly revenues are $8.8M, which are larger than Catheter Precision quarterly revenues of $96K. Sensus Healthcare's net income of $1.2M is higher than Catheter Precision's net income of -$4.1M. Notably, Sensus Healthcare's price-to-earnings ratio is 12.70x while Catheter Precision's PE ratio is 0.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare is 2.86x versus 1.49x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of 13.75% compared to Sensus Healthcare's net margin of -17.98%. Sensus Healthcare's return on equity of 18.5% beat Xtant Medical Holdings's return on equity of -35.98%.

Sensus Healthcare has a consensus price target of $11.50, signalling upside risk potential of 58.84%. On the other hand Xtant Medical Holdings has an analysts' consensus of -- which suggests that it could grow by 338.43%. Given that Xtant Medical Holdings has higher upside potential than Sensus Healthcare, analysts believe Xtant Medical Holdings is more attractive than Sensus Healthcare.

Sensus Healthcare has a beta of 1.215, which suggesting that the stock is 21.498% more volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of 0.343, suggesting its less volatile than the S&P 500 by 65.673%.

Sensus Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sensus Healthcare pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

Sensus Healthcare quarterly revenues are $8.8M, which are smaller than Xtant Medical Holdings quarterly revenues of $27.9M. Sensus Healthcare's net income of $1.2M is higher than Xtant Medical Holdings's net income of -$5M. Notably, Sensus Healthcare's price-to-earnings ratio is 12.70x while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sensus Healthcare is 2.86x versus 0.60x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.